Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review
Research article published in Molecules (Basel, Switzerland) (2017)
Abstract
A rapid and accurate diagnosis in patients with suspected heparin-induced thrombocytopenia (HIT) is essential for patient management but remains challenging. Current HIT diagnosis ideally relies on a combination of clinical information, immunoassay and functional assay results. Platelet activation assays or functional assays detect HIT antibodies that are more clinically significant. Several functional assays have been developed and evaluated in the literature. They differ in the activation endpoint studied; the technique or technology used; the platelet donor selection; the platelet suspension (washed platelets, platelet rich plasma or whole blood); the patient sample (serum or plasma); and the heparin used (type and concentrations). Inconsistencies in controls performed and associated results interpretation are common. Thresholds and performances are determined differently among papers. Functional assays suffer from interlaboratory variability. This lack of standardization limits the evaluation and the accessibility of functional assays in laboratories. In the present article, we review all the current activation endpoints, techniques and methodologies of functional assays developed for HIT diagnosis.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.
Por qué esto importa para la hirudoterapia
Esta revisión examina las pruebas funcionales (de activación plaquetaria) utilizadas para diagnosticar la trombocitopenia inducida por heparina (HIT), detallando cómo difieren en puntos finales, fuentes de plaquetas y metodología, y enfatizando que la falta de estandarización y la variabilidad interlaboratorio limitan su accesibilidad. En el contexto del panorama de la evidencia sobre la hirudoterapia, esto es relevante como antecedentes sobre por qué la complicación inmunológica de la heparina, la HIT, genera interés en los anticoagulantes no heparínicos, incluida la clase de inhibidores directos de la trombina a la que pertenece la molécula derivada de lombriz hirudin. La advertencia es significativa: esta es una revisión metodológica de pruebas diagnósticas que no menciona lombrices, hirudin o hirudoterapia, por lo que es puramente un contexto de apoyo, no evidencia sobre el tratamiento basado en lombrices.
Citación
Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review.
Minet et al. · Molecules (Basel, Switzerland), 2017
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026